Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Isoflavones from soy and red clover exert modest hormonal effects in women, but the relevance to risk of breast cancer is unclear. The aim of this meta-analysis was to assess the effects of isoflavone-rich foods or supplements on a biomarker of breast cancer risk, women's mammographic density. METHODS: Electronic searches were performed on The Cochrane Library, Medline and EMBASE (to June 2009), and reference lists and trial investigators were consulted to identify further studies. Randomized controlled trials (RCTs) of isoflavone-rich foods or supplements versus placebo with a duration of at least 6 months were included in our analysis. Inclusion/exclusion, data extraction and validity assessment were carried out independently in duplicate, and meta-analysis used to pool study results. Subgrouping, sensitivity analysis, assessment of heterogeneity and funnel plots were used to interpret the results. RESULTS: Eight RCTs (1287 women) compared isoflavones with placebo for between 6 months and 3 years. Meta-analysis suggested no overall effect of dietary isoflavones on breast density in all women combined [mean difference (MD) 0.69%, 95% confidence interval (CI) -0.78 to 2.17] or post-menopausal women (MD -1.10%, 95% CI -3.22 to 1.03). However, there was a modest increase in mammographic density in premenopausal women (MD 1.83%, 95% CI 0.25-3.40) without heterogeneity but this effect was lost in one of three sensitivity analyses. CONCLUSIONS: Isoflavone intake does not alter breast density in post-menopausal women, but may cause a small increase in breast density in premenopausal women. Larger, long-term trials are required to determine if these small effects are clinically relevant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 1×
“However, this bias appears to be manifest in studies with subjective outcomes, and not objective ones, suggesting that the masking of outcome assessors to allocation, and method of assessment of breast density may be important in study outcomes (Wood et al., 2008).”
BackgroundPharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 2×
“…image mean index (IMI) which cannot be translated into percent breast density, to be included], (ii) exclude studies wholly funded by industry (Lexchin et al., 2003), and (iii) use the P-values provided for the Powles study ((Powles et al., 2008), as the 95% CIs did not appear to correlate…”
MethodNongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561 · cited 3×
“Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.”
BackgroundMethodImpact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
Pildal, J., Hrobjartsson, A., Jorgensen, K., Hilden, J., Altman, D., & Gotzsche, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym087 · Cited by 472
Kreijkamp-Kaspers, S., Kok, L., Grobbee, D. E., de Haan, E. H. F., Aleman, A., Lampe, J. W., & van der Schouw, Y. T. (2004) · JAMA · doi:10.1001/jama.292.1.65 · Cited by 438
Soy food intake and breast cancer survival
Shu, X. O. (2009) · JAMA · doi:10.1001/jama.2009.1783 · Cited by 436 · cited 4×
“…average intakes of 47 mg/day of isoflavones) was inversely associated with risk of death [hazard ratio (HR) 0.71, 95% confidence interval (CI) 0.54–0.92 for the highest compared with the lowest quartiles of soy intake] and breast cancer recurrence (HR 0.68, 95% CI 0.54–0.87; Shu et al., 2009).”
BackgroundInfluentialEpidemiology of soy exposures and breast cancer risk
Wu, A. H., Yu, M. C., Tseng, C.-C., & Pike, M. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604145 · Cited by 418
Adolescent and adult soy intake and risk of breast cancer in Asian-Americans
Wu, A. H. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1491 · Cited by 406
Childhood soy intake and breast cancer risk in Asian American women
Korde, L. A., Wu, A. H., Fears, T., Nomura, A. M. Y., West, D. W., Kolonel, L. N., Pike, M. C., Hoover, R. N., & Ziegler, R. G. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0405 · Cited by 181 · cited 2×
“The beneficial effects seen in observational studies may relate to lifetime or early life exposure to soy isoflavones, and the strongest and most consistent effect is related to childhood soy intake (Wu et al., 2002; Korde et al., 2009).”
Background
Cited by
Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601
“5–3 years) on the breast density (a biomarker of breast cancer risk) reported no significant effects, although it appeared that there might be a small increase in the breast density of premenopausal women (212).”
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Messina, M. (2016) · Nutrients · doi:10.3390/nu8120754 · Cited by 537
“The “early intake” hypothesis, which was first proposed in 1995 [222,223], is consistent with clinical studies showing that in adults, neither soy protein nor isoflavone supplements affect markers of breast cancer risk including mammographic density [229,230] and breast cell proliferation [231–236].”
ResultDong, J.-Y., & Qin, L.-Q. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1270-8 · Cited by 359
Flavonoids and Cancer Prevention: A Review of the Evidence
Romagnolo, D. F., & Selmin, O. I. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702534 · Cited by 354
The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168
“peutic use of phytoestrogens have been mixed [170, 171].”
Metadata
- Authors
- Hooper, L., Madhavan, G., Tice, J. A., Leinster, S. J., & Cassidy, A.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-28
- Volume
- 16
- Issue
- 6
- Pages
- 745-760
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2140947168
- Cited by
- 104
- References
- 18
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1093/humupd/dmq011
- The paper
- Hooper, L., Madhavan, G., Tice, J. A., Leinster, S. J., & Cassidy, A. (2010). Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Human Reproduction Update. https://doi.org/10.1093/humupd/dmq011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.